1-7 of 7
Keywords: Type II diabetes mellitus
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles

Cardiac autonomic activity and Type II diabetes mellitus

Daniela MANZELLA, Giuseppe PAOLISSO
Journal: Clinical Science
Clin Sci (Lond) (2005) 108 (2): 93–99.
https://doi.org/10.1042/CS20040223
Published: 21 January 2005
... associated with Type II diabetes mellitus [ 35 ] through sustained overactivation of the cardiac sympathetic nervous system. Over the past decade, evidence has been accumulated indicating a double mechanism of action of insulin: a central neural action and a peripheral action. Insulin crosses the blood–brain...
View article titled, Cardiac autonomic activity and <span class="search-highlight">Type</span> <span class="search-highlight">II</span> <span class="search-highlight">diabetes</span> <span class="search-highlight">mellitus</span>
Open the PDF for Cardiac autonomic activity and <span class="search-highlight">Type</span> <span class="search-highlight">II</span> <span class="search-highlight">diabetes</span> <span class="search-highlight">mellitus</span> in another window
Articles

Decreased left ventricular longitudinal contraction in normotensive and normoalbuminuric patients with Type II diabetes mellitus: a Doppler tissue tracking and strain rate echocardiography study

N. H. ANDERSEN, S. H. POULSEN, H. EISKJÆR, P. L. POULSEN, C. E. MOGENSEN
Journal: Clinical Science
Clin Sci (Lond) (2003) 105 (1): 59–66.
https://doi.org/10.1042/CS20020303
Published: 01 July 2003
...N. H. ANDERSEN; S. H. POULSEN; H. EISKJÆR; P. L. POULSEN; C. E. MOGENSEN 30 10 2002 11 2 2003 14 3 2003 14 3 2003 © 2003 The Biochemical Society 2003 echocardiography left ventricle systole tissue Doppler Type II diabetes mellitus Correspondence: Dr...
View article titled, Decreased left ventricular longitudinal contraction in normotensive and normoalbuminuric patients with <span class="search-highlight">Type</span> <span class="search-highlight">II</span> <span class="search-highlight">diabetes</span> <span class="search-highlight">mellitus</span>: a Doppler tissue tracking and strain rate echocardiography study
Open the PDF for Decreased left ventricular longitudinal contraction in normotensive and normoalbuminuric patients with <span class="search-highlight">Type</span> <span class="search-highlight">II</span> <span class="search-highlight">diabetes</span> <span class="search-highlight">mellitus</span>: a Doppler tissue tracking and strain rate echocardiography study in another window
Articles

Residual C-peptide secretion and endothelial function in patients with Type II diabetes

Daniela MANZELLA, Emilia RAGNO, Angela Marie ABBATECOLA, Rodolfo GRELLA, Giuseppe PAOLISSO
Journal: Clinical Science
Clin Sci (Lond) (2003) 105 (1): 113–118.
https://doi.org/10.1042/CS20020291
Published: 01 July 2003
... reactivity C-peptide endothelial function glucagon test homoeostasis model assessment (HOMA) index Type II diabetes mellitus Clinical Science (2003) 105, 113 118 (Printed in Great Britain) 113 Residual C-peptide secretion and endothelial function in patients with Type II diabetes Daniela MANZELLA...
View article titled, Residual C-peptide secretion and endothelial function in patients with Type II diabetes
Open the PDF for Residual C-peptide secretion and endothelial function in patients with Type II diabetes in another window
Articles

Vascular KATP channel blockade by glibenclamide, but not by acarbose, in patients with Type II diabetes

E.J. ABBINK, P. PICKKERS, A. Jansen VAN ROSENDAAL, J.A. LUTTERMAN, C.J. TACK, F.G.M. RUSSEL, P. SMITS
Journal: Clinical Science
Clin Sci (Lond) (2002) 102 (3): 307–314.
https://doi.org/10.1042/cs1020307
Published: 08 February 2002
...% respectively; P < 0.0005). Forearm blood flow responses to acetylcholine, dipyridamole and forearm ischaemia were similar during glibenclamide and acarbose treatment. Thus, in patients with Type II diabetes mellitus, treatment with glibenclamide is associated with an attenuated response to K ATP opening...
View article titled, Vascular KATP channel blockade by glibenclamide, but not by acarbose, in patients with Type II diabetes
Open the PDF for Vascular KATP channel blockade by glibenclamide, but not by acarbose, in patients with Type II diabetes in another window
Articles

Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in Type II diabetes mellitus?

C. RUSTEMEIJER, J. A. SCHOUTEN, H. J. VOERMAN, A. C. BEYNEN, A. J. M. DONKER, R. J. HEINE
Journal: Clinical Science
Clin Sci (Lond) (2001) 101 (1): 29–35.
https://doi.org/10.1042/cs1010029
Published: 23 May 2001
...C. RUSTEMEIJER; J. A. SCHOUTEN; H. J. VOERMAN; A. C. BEYNEN; A. J. M. DONKER; R. J. HEINE Hypertriglyceridaemia is a risk factor for cardiovascular disease in patients suffering from Type II diabetes mellitus, and is due to enhanced synthesis and/or impaired clearance of triacylglycerol-rich...
View article titled, Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in <span class="search-highlight">Type</span> <span class="search-highlight">II</span> <span class="search-highlight">diabetes</span> <span class="search-highlight">mellitus</span>?
Open the PDF for Is pseudocholinesterase activity related to markers of triacylglycerol synthesis in <span class="search-highlight">Type</span> <span class="search-highlight">II</span> <span class="search-highlight">diabetes</span> <span class="search-highlight">mellitus</span>? in another window
Articles

The Pro-115 → Gln mutation in peroxisome-proliferator-activated receptor (PPAR) γ2 is extremely rare in a large cohort of U.S. Caucasians

Jonathan TERRETT, John CHAMBERLAIN, Sohaila RASTAN, Richard MARSHALL, Ralph MCGINNIS, Nigel SPURR, Eamonn O'BRIEN, Catherine EVANS, Andrew RUT
Journal: Clinical Science
Clin Sci (Lond) (2000) 99 (1): 89–90.
https://doi.org/10.1042/cs0990089
Published: 21 June 2000
... ). 27 10 1999 The Biochemical Society and the Medical Research Society © 2000 2000 obesity pharmacogenetics point mutation type II diabetes mellitus transcription factors 89Clinical Science (2000) 99, 89 90 (Printed in Great Britain) + C O R R E S P O N D E N C E The Pro-115!Gln...
View article titled, The Pro-115 → Gln mutation in peroxisome-proliferator-activated receptor (PPAR) γ2 is extremely rare in a large cohort of U.S. Caucasians
Open the PDF for The Pro-115 → Gln mutation in peroxisome-proliferator-activated receptor (PPAR) γ2 is extremely rare in a large cohort of U.S. Caucasians in another window
Articles

Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early Type 2 diabetes

Jeannie F. TODD, C. Mark B. EDWARDS, Mohammad A. GHATEI, Hugh M. MATHER, Stephen R. BLOOM
Journal: Clinical Science
Clin Sci (Lond) (1998) 95 (3): 325–329.
https://doi.org/10.1042/cs0950325
Published: 01 September 1998
...) amide incretin treatment Type II diabetes mellitus 325Clinical Science (1998) 95, 325 329 (Printed in Great Britain) Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early Type 2 diabetes Jeannie F. TODD, C. Mark B. EDWARDS...
View article titled, Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early Type 2 diabetes
Open the PDF for Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early Type 2 diabetes in another window